Download Publications for Leslie Burnett Publications for Leslie Burnett 2016

Publications for Leslie Burnett
Publications for Leslie Burnett
2017
McCaughey, E., Vecellio, E., Lake, R., Li, L.,
Burnett, L., Chesher, D., Braye, S., Mackay, M.,
Gay, S., Badrick, T., et al (2017). Key factors
influencing the incidence of hemolysis: a critical
appraisal of current evidence. Critical Reviews in
Clinical Laboratory Sciences, 54(1), 59-72. <a
href="http://dx.doi.org/10.1080/10408363.2016.
1250247">[More Information]</a>
2016
McCaughey, E., Vecellio, E., Lake, R., Li, L.,
Burnett, L., Chesher, D., Braye, S., Mackay, M.,
Gay, S., Badrick, T., et al (2016). Current
methods of haemolysis detection and reporting as
a source of risk to patient safety: A narrative
review. Clinical Biochemist Reviews, 37(4),
143-151.
2015
Lew, R., Burnett, L., Proos, A., Barlow-Stewart,
K., Delatycki, M., Bankier, A., Aizenberg, H.,
Field, M., Berman, Y., Fleischer, R., et al (2015).
Ashkenazi Jewish population screening for
Tay-Sachs disease: The International and
Australian experience. Journal of Paediatrics
and Child Health, 51(3), 271-279. <a
href="http://dx.doi.org/10.1111/jpc.12632">[Mo
re Information]</a>
Lew, R., Burnett, L., Proos, A., Delatycki, M.
(2015). Tay-Sachs disease: Current perspectives
from Australia. The Application of Clinical
Genetics, 8, 19-25. <a
href="http://dx.doi.org/10.2147/TACG.S49628"
>[More Information]</a>
Ding, L., Burnett, L., Chesher, D. (2015). The
impact of reporting incidental findings from
exome and whole-genome sequencing: predicted
frequencies based on modeling. Genetics in
Medicine, 17(3), 197-204. <a
href="http://dx.doi.org/10.1038/gim.2014.94">[
More Information]</a>
2014
Nguyen, L., Burnett, L. (2014). Automation of
molecular-based analyses: a primer on massively
parallel sequencing. Clinical Biochemist
Reviews, 35(3), 169-176.
Campbell, B., Burnett, L. (2014). Diagnosis of
diabetes in anaemias and haemoglobinopathies:
salutary lessons for improved reporting and
patient empowerment. Pathology, 46(4),
371-372. <a
href="http://dx.doi.org/10.1097/PAT.000000000
0000103">[More Information]</a>
Webster, K., Hill, N., Burnett, L., Deane, E.
(2014). Ectoparasite infestation patterns,
haematology and serum biochemistry of
urban-dwelling common brushtail possums.
Wildlife Biology, 20(4), 206-216. <a
href="http://dx.doi.org/10.2981/wlb.00027">[Mo
re Information]</a>
2013
Neil, A., Pfeffer, S., Burnett, L. (2013).
Benchmarking in pathology: development of a
benchmarking complexity unit and associated
key performance indicators. Pathology, 45(1),
66-70. <a
href="http://dx.doi.org/10.1097/PAT.0b013e328
35b77c4">[More Information]</a>
2012
Burnett, L., Wilson, R., Pfeffer, S., Lowry, J.
(2012). Benchmarking in pathology:
development of an activity-based costing model.
Pathology, 44(7), 644-653. <a
href="http://dx.doi.org/10.1097/PAT.0b013e328
35a9ec4">[More Information]</a>
Lew, R., Proos, A., Burnett, L., Delatycki, M.,
Bankier, A., Fietz, M. (2012). Tay Sachs disease
in Australia: reduced disease incidence despite
stable carrier frequency in Australian Jews.
Medical Journal of Australia, 197(11/12),
652-654. <a
href="http://dx.doi.org/10.5694/mja12.11010">[
More Information]</a>
2011
Lew, R., Burnett, L., Proos, A. (2011).
Tay-Sachs disease preconception screening in
Australia: self-knowledge of being an Ashkenazi
Jew predicts carrier state better than does
ancestral origin, although there is an increased
risk for c.1421 + 1G > C mutation in individuals
with South African heritage. Journal of
Community Genetics, 2(4), 201-209. <a
href="http://dx.doi.org/10.1007/s12687-011-005
7-x">[More Information]</a>
2010
Burnett, D., Burnett, L. (2010). A rare
granulomatous reaction to Q fever vaccination
following influenza vaccination. Medical
Journal of Australia, 193(1), 60. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=20618120">[More Information]</a>
2007
Burnett, L., McQueen, M., Jonsson, J., Torricelli,
F. (2007). IFCC Position Paper: Report of the
IFCC Taskforce on Ethics: Introduction and
framework. Clinical Chemistry and Laboratory
Medicine, 45(8), 1098-1104. <a
href="http://dx.doi.org/10.1515/CCLM.2007.199
">[More Information]</a>
Publications for Leslie Burnett
2006
Field, M., Burnett, L., Sullivan, D., Stewart, P.
(2006). Clinical biochemistry and metabolism.
In NA Boon, NR Colledge, BR Walker, JAA
Hunter (Eds.), Davidson's Principles & Practice
of Medicine, (pp. 419-454). Edinburgh: Churchill
Livingstone.
F. (2004). The International Federation of
Clinical Chemistry and Laboratory Medicine
(IFCC) Ethics Committee: Proposed policy and
draft ethics framework. The International
Federation of Clinical Chemistry and
Laboratory Medicine (IFCC).
2003
Barlow-Stewart, K., Burnett, L. (2006). Ethical
considerations in the use of DNA for the
diagnosis of diseases. Clinical Biochemist
Reviews, 27(1), 53-61. <a
href="http://dx.doi.org/10.1140/epjd/e2006-0007
0-x">[More Information]</a>
Barlow-Stewart, K., Burnett, L., Proos, A.,
Howell, V., Huq, F., Lazarus, R., Aizenberg, H.
(2003). A genetic screening programme for
Tay-Sachs disease and cystic fibrosis for
Australian Jewish high School students. Journal
of Medical Genetics, 40(e45), 1-8.
2005
Burnett, L. (2003). Making national DNA
databases safer. The Lancet, 362(9397),
1761-1762. <a
href="http://dx.doi.org/10.1016/S0140-6736(03)
14861-1">[More Information]</a>
Field, M., Burnett, L., Sullivan, D., Stewart, P.
(2005). Biochemical Disorders. In N Boon, N
Colledge, B Walker, J Hunter (Eds.), Davidson's
Principles and Practice of Medicine (20 Ed.),
(pp. 1-2). United Kingdom: Elsevier.
Field, M., Burnett, L., Sullivan, D., Stewart, P.
(2005). Clinical biochemistry and metabolism.
In Nicholas A. Boon, Nicki R. Colledge, Brian
R. Walker and John Hunter (Eds.), Davidson's
Principles and Practice of Medicine, (pp.
419-454). Churchill Livingstone.
Warren, E., Anderson, R., Proos, A., Burnett, L.,
Barlow-Stewart, K., Hall, J. (2005).
Cost-effectiveness of a school-based Tay-Sachs
and cystic fibrosis genetic carrier screening
program. Genetics in Medicine, 7(7), 484-494.
<a
href="http://dx.doi.org/10.1097/01.gim.0000178
496.91670.3b">[More Information]</a>
2004
McKenzie, S., Deane, E., Burnett, L. (2004). Are
Serum Cortisol Levels A Reliable Indicator Of
Wellbeing In The Tammar Wallaby, Macropus
Eugenii? Comparative Biochemistry and
Physiology. Part A: Molecular and Integrative
Physiology, 138(3), 341-348. <a
href="http://dx.doi.org/10.1016/j.cbpb.2004.05.0
04">[More Information]</a>
Howell, V., Proos, A., La Rue, D., Jensen, C.,
Beach, F., Burnett, L. (2004). Carrier Screening
For Canavan Disease In Australia. Journal of
Inherited Metabolic Disease (JIMD), 27(2),
289-290. <a
href="http://dx.doi.org/10.1023/B:BOLI.000002
8837.63607.f0">[More Information]</a>
Burnett, L., Chesher, D., Mudaliar, Y. (2004).
Improving The Quality Of Information On
Pathology Request Forms. Annals of Clinical
Biochemistry, 41(1), 53-56. <a
href="http://dx.doi.org/10.1258/0004563043226
64708">[More Information]</a>
Burnett, L., McQueen, M., Jonsson, J., Torricelli,
Burnett, L., Barlow-Stewart, K., Proos, A.,
Aizenberg, H. (2003). The "GeneTrustee": a
universal identificaiton system that ensures
privacy and confidentiality for human genetic
databases. Journal of Law and Medicine, 10(4),
506-513.
2002
Burnett, L., Chesher, D., Groot-Obbink, D.,
Hegedus, G., Mackay, M., Proos, A., Rochester,
C., Shaw, W., Webber, A. (2002). ISO compliant
laboratory quality systems and incident
monitoring improve the implementation of
laboratory information systems. Accreditation
And Quality Assurance, 7(6), 237-241.
Burnett, L., Chesher, D., Burnett, J. (2002).
Optimizing the availability of 'stat' laboratory
tests using Shewhart 'c' control charts. Annals of
Clinical Biochemistry, 39(2), 140-144.
Burnett, L. (2002). Pathology Indicators. In
Aust Council on Healthcare Standards (Eds.),
The Australian Council on Healthcare
Standards: Clinical Indicator User's Manual,
(pp. 231-234). Australia: Australian Council on
Healthcare Standards.